166 related articles for article (PubMed ID: 33160327)
1. Gridlock from diagnosis to treatment of multidrug resistant tuberculosis (MDR-TB) in Tanzania: patients' perspectives from a focus group discussion.
Mpagama SG; Ezekiel MJ; Mbelele PM; Chongolo AM; Kibiki GS; de Guex KP; Heysell SK
BMC Public Health; 2020 Nov; 20(1):1667. PubMed ID: 33160327
[TBL] [Abstract][Full Text] [Related]
2. Gridlock from diagnosis to treatment of multidrug-resistant tuberculosis in Tanzania: low accessibility of molecular diagnostic services and lack of healthcare worker empowerment in 28 districts of 5 high burden TB regions with mixed methods evaluation.
Mpagama SG; Mbelele PM; Chongolo AM; Lekule IA; Lyimo JJ; Kibiki GS; Heysell SK
BMC Public Health; 2019 Apr; 19(1):395. PubMed ID: 30971228
[TBL] [Abstract][Full Text] [Related]
3. Pathways to multidrug-resistant tuberculosis diagnosis and treatment initiation: a qualitative comparison of patients' experiences in the era of rapid molecular diagnostic tests.
Naidoo P; van Niekerk M; du Toit E; Beyers N; Leon N
BMC Health Serv Res; 2015 Oct; 15():488. PubMed ID: 26511931
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and interim treatment outcomes from the first cohort of multidrug-resistant tuberculosis patients in Tanzania.
Mpagama SG; Heysell SK; Ndusilo ND; Kumburu HH; Lekule IA; Kisonga RM; Gratz J; Boeree MJ; Houpt ER; Kibiki GS
PLoS One; 2013; 8(5):e62034. PubMed ID: 23675411
[TBL] [Abstract][Full Text] [Related]
5. Financial barriers and coping strategies: a qualitative study of accessing multidrug-resistant tuberculosis and tuberculosis care in Yunnan, China.
Hutchison C; Khan MS; Yoong J; Lin X; Coker RJ
BMC Public Health; 2017 Feb; 17(1):221. PubMed ID: 28222724
[TBL] [Abstract][Full Text] [Related]
6. Project extension for community healthcare outcomes improves care and treatment for multidrug-resistant tuberculosis patients in Tanzania.
Peter DD; Mziray SR; Lekule IA; Kitundu V; Mohamed S; Kisonga RM; Mpagama SG; Struminger BB
Int J Mycobacteriol; 2021; 10(2):182-187. PubMed ID: 34558472
[TBL] [Abstract][Full Text] [Related]
7. Barriers to access and adherence to tuberculosis services, as perceived by patients: A qualitative study in Mozambique.
De Schacht C; Mutaquiha C; Faria F; Castro G; Manaca N; Manhiça I; Cowan J
PLoS One; 2019; 14(7):e0219470. PubMed ID: 31291352
[TBL] [Abstract][Full Text] [Related]
8. Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan.
Horter S; Stringer B; Gray N; Parpieva N; Safaev K; Tigay Z; Singh J; Achar J
BMC Infect Dis; 2020 Sep; 20(1):675. PubMed ID: 32938422
[TBL] [Abstract][Full Text] [Related]
9. Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views.
Engel N; Ochodo EA; Karanja PW; Schmidt BM; Janssen R; Steingart KR; Oliver S
Cochrane Database Syst Rev; 2022 Apr; 4(4):CD014877. PubMed ID: 35470432
[TBL] [Abstract][Full Text] [Related]
10. Addressing patients' unmet needs related to multidrug-resistant tuberculosis (MDR-TB) care: A qualitative research study from Pune city, India.
Atre S; Jagtap J; Faqih M; Dumbare Y; Sawant T; Ambike S; Farhat M
PLoS One; 2023; 18(12):e0295508. PubMed ID: 38153918
[TBL] [Abstract][Full Text] [Related]
11. Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania.
Juma SP; Maro A; Pholwat S; Mpagama SG; Gratz J; Liyoyo A; Houpt ER; Kibiki GS; Mmbaga BT; Heysell SK
BMC Infect Dis; 2019 Feb; 19(1):129. PubMed ID: 30732572
[TBL] [Abstract][Full Text] [Related]
12. Hospitalized care for MDR-TB in Port Harcourt, Nigeria: a qualitative study.
Bieh KL; Weigel R; Smith H
BMC Infect Dis; 2017 Jan; 17(1):50. PubMed ID: 28068907
[TBL] [Abstract][Full Text] [Related]
13. Community-based management of multiple drug resistant tuberculosis in a tertiary hospital in Tanzania: a best practice implementation project.
Jelly I; Peters MDJ
JBI Database System Rev Implement Rep; 2017 Dec; 15(12):3092-3101. PubMed ID: 29219878
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting time to treatment initiation after diagnosis for multidrug-resistant/rifampicin-resistant tuberculosis patients: A mixed-methods study in Jakarta, Indonesia.
Silitonga P; Jiang W; Wyatt S; Burhan E; Kes EFM; Long Q
Trop Med Int Health; 2023 Jan; 28(1):43-52. PubMed ID: 36477995
[TBL] [Abstract][Full Text] [Related]
15. Effect of reliance on Xpert MTB/RIF on time to treatment and multidrug-resistant tuberculosis treatment outcomes in Tanzania: a retrospective cohort study.
Mollel E; Lekule I; Lynen L; Decroo T
Int Health; 2019 Nov; 11(6):520-527. PubMed ID: 30806660
[TBL] [Abstract][Full Text] [Related]
16. Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers.
Thomas BE; Kumar JV; Periyasamy M; Khandewale AS; Hephzibah Mercy J; Raj EM; Kokila S; Walgude AS; Gaurkhede GR; Kumbhar JD; Ovung S; Paul M; Rajkumar BS; Subbaraman R
J Med Internet Res; 2021 Jun; 23(6):e23294. PubMed ID: 34110300
[TBL] [Abstract][Full Text] [Related]
17. Gridlock from Diagnosis to Treatment of Multidrug-Resistant Tuberculosis (MDR-TB) in Tanzania: Illuminating Potential Factors for Possible Intervention.
Liyoyo AA; Heysell SK; Kisonga RM; Lyimo JJ; Mleoh LJ; Mutayoba BK; Lekule IA; Mmbaga BT; Kibiki GS; Mpagama SG
East Afr Health Res J; 2017; 1(1):31-39. PubMed ID: 34308156
[TBL] [Abstract][Full Text] [Related]
18. Mycobactericidal Effects of Different Regimens Measured by Molecular Bacterial Load Assay among People Treated for Multidrug-Resistant Tuberculosis in Tanzania.
Mbelele PM; Mpolya EA; Sauli E; Mtafya B; Ntinginya NE; Addo KK; Kreppel K; Mfinanga S; Phillips PPJ; Gillespie SH; Heysell SK; Sabiiti W; Mpagama SG
J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33536294
[TBL] [Abstract][Full Text] [Related]
19. Exploring health care providers' engagement in prevention and management of multidrug resistant Tuberculosis and its factors in Hadiya Zone health care facilities: qualitative study.
Lajore BA; Aweke YH; Ayanto SY; Ayele M
BMC Health Serv Res; 2024 Apr; 24(1):542. PubMed ID: 38678263
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
